Review



retn polyclonal antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Proteintech retn polyclonal antibody
    Imageological-proteomic analysis of chordoma (A) Representative CT manifestation of sclerotic and osteolytic chordoma. Protein levels (B) and Representative IHC images (C) of <t>RETN</t> in chordoma with or without bone destruction. GSEA enrichment analysis of DEPs between chordoma with or without bone destruction revealed statistic difference in degradation of the ECM (D) and osteopontin signaling (E). (F) Representative T1-weighted images of MRI for chordoma (hypointensity, isointensity, heterogeneous hyperintensity). (G) Kaplan-Meier curve of OS between hypo-/iso-intensity and heterogeneous hyperintensity. Protein levels (H) and representative IHC images (I) of AHNAK2 in chordoma hypo-/iso-intensity or heterogeneous hyperintensity. GSEA enrichment analysis of DEPs between hypo-/iso-intensity and heterogeneous hyperintensity revealed statistic difference in mTORC1 signaling (J) and G2M DNA damage checkpoint (K). Abbreviations: CT, computed tomography; IHC, immunohistochemistry; OS, overall survival; DEPs, differentially expressed proteins; GSEA, gene set enrichment analysis; ECM, extracellular matrix; MRI, magnetic resonance imaging.
    Retn Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/retn+polyclonal+antibody/Human+Resistin+ELISA+Kit/pmc11513834-109-0-4
    Average 93 stars, based on 5 article reviews
    retn polyclonal antibody - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "Clinical-proteomic classification and precision treatment strategy of chordoma"

    Article Title: Clinical-proteomic classification and precision treatment strategy of chordoma

    Journal: Cell Reports Medicine

    doi: 10.1016/j.xcrm.2024.101757

    Imageological-proteomic analysis of chordoma (A) Representative CT manifestation of sclerotic and osteolytic chordoma. Protein levels (B) and Representative IHC images (C) of RETN in chordoma with or without bone destruction. GSEA enrichment analysis of DEPs between chordoma with or without bone destruction revealed statistic difference in degradation of the ECM (D) and osteopontin signaling (E). (F) Representative T1-weighted images of MRI for chordoma (hypointensity, isointensity, heterogeneous hyperintensity). (G) Kaplan-Meier curve of OS between hypo-/iso-intensity and heterogeneous hyperintensity. Protein levels (H) and representative IHC images (I) of AHNAK2 in chordoma hypo-/iso-intensity or heterogeneous hyperintensity. GSEA enrichment analysis of DEPs between hypo-/iso-intensity and heterogeneous hyperintensity revealed statistic difference in mTORC1 signaling (J) and G2M DNA damage checkpoint (K). Abbreviations: CT, computed tomography; IHC, immunohistochemistry; OS, overall survival; DEPs, differentially expressed proteins; GSEA, gene set enrichment analysis; ECM, extracellular matrix; MRI, magnetic resonance imaging.
    Figure Legend Snippet: Imageological-proteomic analysis of chordoma (A) Representative CT manifestation of sclerotic and osteolytic chordoma. Protein levels (B) and Representative IHC images (C) of RETN in chordoma with or without bone destruction. GSEA enrichment analysis of DEPs between chordoma with or without bone destruction revealed statistic difference in degradation of the ECM (D) and osteopontin signaling (E). (F) Representative T1-weighted images of MRI for chordoma (hypointensity, isointensity, heterogeneous hyperintensity). (G) Kaplan-Meier curve of OS between hypo-/iso-intensity and heterogeneous hyperintensity. Protein levels (H) and representative IHC images (I) of AHNAK2 in chordoma hypo-/iso-intensity or heterogeneous hyperintensity. GSEA enrichment analysis of DEPs between hypo-/iso-intensity and heterogeneous hyperintensity revealed statistic difference in mTORC1 signaling (J) and G2M DNA damage checkpoint (K). Abbreviations: CT, computed tomography; IHC, immunohistochemistry; OS, overall survival; DEPs, differentially expressed proteins; GSEA, gene set enrichment analysis; ECM, extracellular matrix; MRI, magnetic resonance imaging.

    Techniques Used: Computed Tomography, Immunohistochemistry, Magnetic Resonance Imaging


    Figure Legend Snippet:

    Techniques Used: Diagnostic Assay, Recombinant, Sequencing, Software

    Related Articles

    Computed Tomography:

    Article Title: Single-cell RNA profiling reveals classification and characteristics of mononuclear phagocytes in colorectal cancer
    Article Snippet: RETN Polyclonal antibody , proteintech , Cat No. 18170-1-AP.

    Article Title: Clinical-proteomic classification and precision treatment strategy of chordoma
    Article Snippet: RETN Polyclonal antibody , Proteintech , Cat# 18170-1-AP; RRID: AB_2918058.

    Immunohistochemistry:

    Article Title: Single-cell RNA profiling reveals classification and characteristics of mononuclear phagocytes in colorectal cancer
    Article Snippet: RETN Polyclonal antibody , proteintech , Cat No. 18170-1-AP.

    Article Title: Clinical-proteomic classification and precision treatment strategy of chordoma
    Article Snippet: RETN Polyclonal antibody , Proteintech , Cat# 18170-1-AP; RRID: AB_2918058.

    Magnetic Resonance Imaging:

    Article Title: Single-cell RNA profiling reveals classification and characteristics of mononuclear phagocytes in colorectal cancer
    Article Snippet: RETN Polyclonal antibody , proteintech , Cat No. 18170-1-AP.

    Article Title: Clinical-proteomic classification and precision treatment strategy of chordoma
    Article Snippet: RETN Polyclonal antibody , Proteintech , Cat# 18170-1-AP; RRID: AB_2918058.

    Diagnostic Assay:

    Article Title: Single-cell RNA profiling reveals classification and characteristics of mononuclear phagocytes in colorectal cancer
    Article Snippet: RETN Polyclonal antibody , proteintech , Cat No. 18170-1-AP.

    Article Title: Clinical-proteomic classification and precision treatment strategy of chordoma
    Article Snippet: RETN Polyclonal antibody , Proteintech , Cat# 18170-1-AP; RRID: AB_2918058.

    Recombinant:

    Article Title: Single-cell RNA profiling reveals classification and characteristics of mononuclear phagocytes in colorectal cancer
    Article Snippet: RETN Polyclonal antibody , proteintech , Cat No. 18170-1-AP.

    Article Title: Clinical-proteomic classification and precision treatment strategy of chordoma
    Article Snippet: RETN Polyclonal antibody , Proteintech , Cat# 18170-1-AP; RRID: AB_2918058.

    Sequencing:

    Article Title: Single-cell RNA profiling reveals classification and characteristics of mononuclear phagocytes in colorectal cancer
    Article Snippet: RETN Polyclonal antibody , proteintech , Cat No. 18170-1-AP.

    Article Title: Clinical-proteomic classification and precision treatment strategy of chordoma
    Article Snippet: RETN Polyclonal antibody , Proteintech , Cat# 18170-1-AP; RRID: AB_2918058.

    Software:

    Article Title: Single-cell RNA profiling reveals classification and characteristics of mononuclear phagocytes in colorectal cancer
    Article Snippet: RETN Polyclonal antibody , proteintech , Cat No. 18170-1-AP.

    Article Title: Clinical-proteomic classification and precision treatment strategy of chordoma
    Article Snippet: RETN Polyclonal antibody , Proteintech , Cat# 18170-1-AP; RRID: AB_2918058.



    Similar Products

    93
    Proteintech retn polyclonal antibody
    Imageological-proteomic analysis of chordoma (A) Representative CT manifestation of sclerotic and osteolytic chordoma. Protein levels (B) and Representative IHC images (C) of <t>RETN</t> in chordoma with or without bone destruction. GSEA enrichment analysis of DEPs between chordoma with or without bone destruction revealed statistic difference in degradation of the ECM (D) and osteopontin signaling (E). (F) Representative T1-weighted images of MRI for chordoma (hypointensity, isointensity, heterogeneous hyperintensity). (G) Kaplan-Meier curve of OS between hypo-/iso-intensity and heterogeneous hyperintensity. Protein levels (H) and representative IHC images (I) of AHNAK2 in chordoma hypo-/iso-intensity or heterogeneous hyperintensity. GSEA enrichment analysis of DEPs between hypo-/iso-intensity and heterogeneous hyperintensity revealed statistic difference in mTORC1 signaling (J) and G2M DNA damage checkpoint (K). Abbreviations: CT, computed tomography; IHC, immunohistochemistry; OS, overall survival; DEPs, differentially expressed proteins; GSEA, gene set enrichment analysis; ECM, extracellular matrix; MRI, magnetic resonance imaging.
    Retn Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/retn+polyclonal+antibody/Human+Resistin+ELISA+Kit/pmc11513834-109-0-4
    Average 93 stars, based on 1 article reviews
    retn polyclonal antibody - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    R&D Systems polyclonal antibody mouse retn
    Imageological-proteomic analysis of chordoma (A) Representative CT manifestation of sclerotic and osteolytic chordoma. Protein levels (B) and Representative IHC images (C) of <t>RETN</t> in chordoma with or without bone destruction. GSEA enrichment analysis of DEPs between chordoma with or without bone destruction revealed statistic difference in degradation of the ECM (D) and osteopontin signaling (E). (F) Representative T1-weighted images of MRI for chordoma (hypointensity, isointensity, heterogeneous hyperintensity). (G) Kaplan-Meier curve of OS between hypo-/iso-intensity and heterogeneous hyperintensity. Protein levels (H) and representative IHC images (I) of AHNAK2 in chordoma hypo-/iso-intensity or heterogeneous hyperintensity. GSEA enrichment analysis of DEPs between hypo-/iso-intensity and heterogeneous hyperintensity revealed statistic difference in mTORC1 signaling (J) and G2M DNA damage checkpoint (K). Abbreviations: CT, computed tomography; IHC, immunohistochemistry; OS, overall survival; DEPs, differentially expressed proteins; GSEA, gene set enrichment analysis; ECM, extracellular matrix; MRI, magnetic resonance imaging.
    Polyclonal Antibody Mouse Retn, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/retn+polyclonal+antibody/Anti-PAR+Polyclonal+Antibody+(Rabbit)/pmc04647653-56-18-23
    Average 90 stars, based on 1 article reviews
    polyclonal antibody mouse retn - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Imageological-proteomic analysis of chordoma (A) Representative CT manifestation of sclerotic and osteolytic chordoma. Protein levels (B) and Representative IHC images (C) of RETN in chordoma with or without bone destruction. GSEA enrichment analysis of DEPs between chordoma with or without bone destruction revealed statistic difference in degradation of the ECM (D) and osteopontin signaling (E). (F) Representative T1-weighted images of MRI for chordoma (hypointensity, isointensity, heterogeneous hyperintensity). (G) Kaplan-Meier curve of OS between hypo-/iso-intensity and heterogeneous hyperintensity. Protein levels (H) and representative IHC images (I) of AHNAK2 in chordoma hypo-/iso-intensity or heterogeneous hyperintensity. GSEA enrichment analysis of DEPs between hypo-/iso-intensity and heterogeneous hyperintensity revealed statistic difference in mTORC1 signaling (J) and G2M DNA damage checkpoint (K). Abbreviations: CT, computed tomography; IHC, immunohistochemistry; OS, overall survival; DEPs, differentially expressed proteins; GSEA, gene set enrichment analysis; ECM, extracellular matrix; MRI, magnetic resonance imaging.

    Journal: Cell Reports Medicine

    Article Title: Clinical-proteomic classification and precision treatment strategy of chordoma

    doi: 10.1016/j.xcrm.2024.101757

    Figure Lengend Snippet: Imageological-proteomic analysis of chordoma (A) Representative CT manifestation of sclerotic and osteolytic chordoma. Protein levels (B) and Representative IHC images (C) of RETN in chordoma with or without bone destruction. GSEA enrichment analysis of DEPs between chordoma with or without bone destruction revealed statistic difference in degradation of the ECM (D) and osteopontin signaling (E). (F) Representative T1-weighted images of MRI for chordoma (hypointensity, isointensity, heterogeneous hyperintensity). (G) Kaplan-Meier curve of OS between hypo-/iso-intensity and heterogeneous hyperintensity. Protein levels (H) and representative IHC images (I) of AHNAK2 in chordoma hypo-/iso-intensity or heterogeneous hyperintensity. GSEA enrichment analysis of DEPs between hypo-/iso-intensity and heterogeneous hyperintensity revealed statistic difference in mTORC1 signaling (J) and G2M DNA damage checkpoint (K). Abbreviations: CT, computed tomography; IHC, immunohistochemistry; OS, overall survival; DEPs, differentially expressed proteins; GSEA, gene set enrichment analysis; ECM, extracellular matrix; MRI, magnetic resonance imaging.

    Article Snippet: RETN Polyclonal antibody , Proteintech , Cat# 18170-1-AP; RRID: AB_2918058.

    Techniques: Computed Tomography, Immunohistochemistry, Magnetic Resonance Imaging

    Journal: Cell Reports Medicine

    Article Title: Clinical-proteomic classification and precision treatment strategy of chordoma

    doi: 10.1016/j.xcrm.2024.101757

    Figure Lengend Snippet:

    Article Snippet: RETN Polyclonal antibody , Proteintech , Cat# 18170-1-AP; RRID: AB_2918058.

    Techniques: Diagnostic Assay, Recombinant, Sequencing, Software